NARA Discovery
Article Details
← Back to Search Results
Journal Article

A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo

Kenneth R. LaMontagne; Jeannene Butler; Virna B. Borowski; Angel R. Fuentes-Pesquera; Jonathan M. Blevitt; Shenlin Huang; Ronghua Li; Peter J. Connolly; Lee M. Greenberger
Angiogenesis · Vol. 12, Issue 3 · pp. 287-296 · 2009
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalAngiogenesis
PublisherSpringer
Publication Date2009-09-01
Publication Year2009
Volume12
Issue3
Pages287-296
Document TypeJournal Article
eISSN1573-7209
DOI10.1007/s10456-009-9151-7

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10456
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.